Atlas Trials

A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)

Clinical trial NCT00990496 · TERMINATED

Trial details

NCT number
NCT00990496
Sponsor
Milton S. Hershey Medical Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2009-09-01
Primary completion
2010-10-28
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.